Skip to content

Clinical trials

Phase 3 Carcinoma, Renal Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20061
20071
20082
20102
20112
20121
20131
20141
20162
20173
20192
20212
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting5
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Pfizer4
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals3
Bayer2
Bristol-Myers Squibb2
Exelixis2
Hoffmann-La Roche2
AstraZeneca1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell30
Kidney Neoplasms10
Neoplasms4
Carcinoma2
Neoplasm Metastasis2
Carcinoma, Hepatocellular1
Gastrointestinal Stromal Tumors1
Kidney Diseases1
Recurrence1
Stomatitis1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.